BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, January 27, 2026
Home » Authors » Mark McCarty

Articles by Mark McCarty

Washington roundup: FDA wastes no time in inking warning to guidewire maker

March 11, 2010
By Mark McCarty

Washington roundup: AdvaMed's new board chairman says no drastic changes in store

March 10, 2010
By Mark McCarty

Washington roundup: Senate Judiciary offers yet another patent reform bill

March 9, 2010
By Mark McCarty

Washington roundup: Cardiac Science warning hints resistors drove recall of AEDs

March 4, 2010
By Mark McCarty

Washington roundup: Menaflex redux: FDA convenes advisory panel for another look

March 3, 2010
By Mark McCarty

Washington roundup: Imaging radiation issue seen as addressed by accreditation

March 2, 2010
By Mark McCarty

Washington roundup: MITA reports safeguards for CT equipment to address dosing

March 1, 2010
By Mark McCarty

Washington roundup: AdvaMed commissions study of comparative med-tech innovation

Feb. 26, 2010
By Mark McCarty

Shuren cites tension between predictability and adaptability

Feb. 25, 2010
By Mark McCarty
WASHINGTON — Tuesday served as the last day of CRT (Cardiovascular Research Technologies) 2010, sponsored by the Cardiovascular Research Institute (Washington), and included a lunchtime discussion session offering views of how healthcare reform might affect the device industry, but a previous session gave Jeffrey Shuren, MD, the chief of the Center for Devices and Radiological Health, a chance to further explain where he expects to steer the center in the next couple of years. (Medical Device Daily)
Read More

Round table fails to square several device trial issues

Feb. 24, 2010
By Mark McCarty
WASHINGTON – Monday's goings-on at CRT (Cardiovascular Research Technologies) 2010, sponsored by the Cardiovascular Research Institute (Washington), included an afternoon session during which a number of FDAers opted to use their microphone time to give a common-knowledge review of the functions of their offices. However, a round-table discussion offered some tidbits in exchange for the attendees' time, including a review of continued enrollment in device trials and issues in connection with harvesting of valves after the patient has expired. (Medical Device Daily)
Read More
Previous 1 2 … 490 491 492 493 494 495 496 497 498 … 579 580 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 26, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 23, 2026.
  • Illustration of magnifying glass inspecting brain

    Neurotrimin unveiled as marker in intellectual disability

    BioWorld Science
    Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
  • DNA mutations or genetic disorder concept art

    Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease

    BioWorld Science

    Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...

  • Illustration of human body surrounded by DNA, cell and drug icons

    Cell/gene therapy sector now sustainable; China competition mounting

    BioWorld
    There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing